Obesity as a Vertical Risk Amplifier in STEMI Across CKM Syndrome Stages: Accelerated Onset and Impaired Myocardial Reperfusion Despite Timely Intervention

Authors:

Abstract
Background and Objective: The Cardiovascular-Kidney-Metabolic (CKM) syndrome framework provides a meaningful risk stratification strategy, yet obesity’s independent prognostic role in ST-elevation myocardial infarction (STEMI) remains debated. We investigated the association of obesity with clinical outcomes across CKM syndrome stages within the Brazilian B-Care cohort.Method: This study evaluated 4,004 consecutive individuals hospitalized for STEMI in the Federal District, Brazil (2009–2019). Patients were stratified into CKM stages (0/1, 2/3, and 4) and compared by the presence of obesity. Primary outcomes included all-cause mortality and major adverse cardiovascular events (MACE).Results: Obesity (31% of the cohort) accelerated STEMI onset by approximately 4.2 years across all CKM stages. Despite comparable reperfusion process times (p>0.05), obese patients achieved significantly poorer myocardial reperfusion quality, with lower rates of TIMI 3 flow and myocardial blush grade 3 (TIMI 3 in CKM 4: 74.5% vs. 82.1%; p < 0.05). Obesity consistently amplified mortality risk, ranging from aHR 2.7 (CKM 1) to 6.14 (CKM 4). Notably, obese patients in intermediate CKM stages (2/3) faced mortality risks comparable to non-obese patients with overt disease (CKM 4).Conclusion: Obesity functions as a vertical risk amplifier across the CKM spectrum, accelerating disease onset and significantly worsening long-term prognosis. The dissociation between adequate procedural timing and inferior tissue-level reperfusion highlights a heightened ischemic vulnerability in obese patients. Therefore, obesity must be prioritized as a primary, independent driver of cardiovascular risk that necessitates targeted microvascular protection strategies beyond conventional risk scores